S1470-2045(12)70412-6. Featuring Chris Boshoff, University College London
Cancer Insrtute. Read in full here. A subset analysis of this CR-UK funded phase
...
Advancing Discoveries to Beat Cancer
INSIGHT SCIENCE IN THE SPOTLIGHT
!"#"$%&$"'(&)$*&+,-./#)01$(&2314&5!678&2,$*"*& (#/"$0(%(
MEET THE SCIENTIST Professor Charles Swanton
!"#$"%&"'"(%)*'+",%-.%/0'1#"021%10'1"#
Group Leader of the W3)$(.)01$).&5)$#"3& WX"3)+",0#(&>W5WB& laboratory at the 5)$#"3&!"(")3#X&78& London Research P$(0%,%":
!"#$%&"'$($"#$&%()&#*+&,(%&-&".("/&%%"'*#,(0#("1*#()203"#$&(4"567"8()&#&, 9:&;:&JH?HBK&LII6H@M:&NOPKA@:A@LQR$)%,3"AAMHJ S")%,3/$E&N)F/*&T:&9*)4(U&V)$E"3&P$(0%,%"&)$*&N)F/*&9:&W,F"(1$U&5)4-3/*E"& !"(")3#X&P$(0%,%" Read in full here
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
Being rash with cancer drugs 90%,5:.0#&(&%.*'#0/(0#(4"',(7056("3-"#$&3(#*#:,+"..:$&..(.2#)( $"#$&%(2#,205"/.&(;*%($6&+*56&%"48(!?@ABCD("(3*2/.&:/.0#3E(4."$&/*:$*#5%*..&3E( 46",&(F(5%0". V:&`:&a""&"%&).:&>?@A?B:&CS/3(%6./$"&"3.10$/-&/$&+)0"$%(&'/%X&)*F)$#"*&$1$6(4)..6#"..& .,$E&#)$#"3&,$(,/%)-."&213&#X"41%X"3)+Y&>WODP59aBK&)&*1,-."6-./$*U&+.)#"-16 #1$%31.."*U&+X)("&L&%3/).:_&The Lancet Oncology&AL>AABK&AAbA6AAJ@:&NOPK&A@:A@AbR VAHJ@6?@HM>A?BJ@HA?6b S")%,3/$E&5X3/(&dV5a5B&'X1&'"3"&*""4"*&,$(,/%)-."&213& #X"41%X"3)+Y&c&(X1'"*&%X)%&+)0"$%(&'X1&3"#"/F"*&"3.10$/-&)$*&(,-("e,"$%.Y& *"F".1+"*&)&3)(X&(,3F/F"*&.1$E"3&%X)$&+)0"$%(&'X1&3"#"/F"*&"/%X"3&)&+.)#"-1&13& %X1("&'X1&*/*$[%&*"F".1+&%X"&3)(X&)f"3&%X"/3&g3(%&#Y#."&12&"3.10$/-:&^X/.(%&%X"& %3/).U&'X/#X&3"#3,/%"*&-"%'""$&?@@M&)$*&?@@IU&*/*&$1%&/$#.,*"&%X/(&)(&)&+3"6& *"%"34/$"*&(,-("%&)$).Y(/(U&%X"&*)%)&(X1'(&%X)%&%X/(&4)Y&-"&)&+1%"$0).&%3")%4"$%& 213&dV5a5&+)0"$%(&'/%X&$1&1%X"3&)F)/.)-."&1+01$(U&,(/$E&)-("$#"&12&)&g3(%6#Y#."& 3)(X&)(&)&-/14)3="3&%1&*/(#1$0$,"&%X"&%X"3)+Y:
1995&DXNU&P4+"3/).&5)$#"3&!"(")3#X&S,$*U&78 2002&`"4-"3(X/+&!1Y).&51.."E"&12&DXY(/#/)$( 2004 Established lab at the London !"(")3#X&P$(0%,%"U&5!678 2011 Appointed Chair in Personalised Cancer `"*/#/$"U&75a&5)$#"3&P$(0%,%"
8'-#.,412.' P$&)&.)$*4)3=&(%,*YU&+,-./(X"*&/$&%X"&d"'& h$E.)$*&T1,3$).&12&`"*/#/$"&.)(%&`)3#XU&X/(& E31,+&/*"$0g"*&%X)%&%)=/$E&)&()4+."&2314& i,(%&1$"&+)3%&12&)&%,41,3&4)Y&$1%&E/F"&)&2,..& +/#%,3"&12&/%(&E"$"0#&.)$*(#)+"U&+1%"$0)..Y& X".+/$E&%1&"G+.)/$&'XY&)j"4+%(&)%&,(/$E& (/$E."&-/1+(/"(&%1&/*"$02Y&-/14)3="3(&%1& 'X/#X&+"3(1$)./("*&#)$#"3&%3")%4"$%(&#)$&-"& %)3E"%"*&X)F"&$1%&-""$&413"&(,##"((2,.: 9&Y")3&1$U&'"&)(=&D312"((13&V')$%1$&)-1,%& %X"&/4+)#%&12&X/(&g$*/$E(K Describe the response to the paper? WX"&+)+"3&')(&F"3Y&'"..&3"#"/F"*U&)$*&X)(& -""$&"G%"$(/F".Y&#/%"*k&)++)3"$%.Y&/%&')(& second only to the Higgs Boson paper for ref6 "3"$#"(&/$&?@A?l&V+")=/$E&)%&F)3/1,(&4""0$E(& %X"&3"(")3#X&(""4(&%1&X)F"&-""$&/$%"3+3"%"*& /$&)&2"'&*/\"3"$%&')Y(U&(14"&413"&1+04/(0#& %X)$&1%X"3(U&3"E)3*/$E&%X"&2,%,3"&%3")%4"$%& .)$*(#)+"&12&%X/(&*/(")(":&9+)3%&2314&X/EX6 ./EX0$E&%X"&*/m#,.0"(&12&/*"$02Y/$E&E11*&-/6 14)3="3(U&P&2"".&%X"&="Y&4"(()E"&/(&%X)%&'X"3"& +1((/-."&'"&(X1,.*&)/4&%1&%)3E"%&,-/e,/%1,(& %,41,3&*3/F"3&"F"$%(&/$&%X"&%,41,3&]%3,$=[U& 3)%X"3&%X)$&%X"&4)$Y&]-3)$#X[&4,%)01$(U& 'X/#X&*/\"3&)#31((&)&%,41,3:&WX"3"&#.")3.Y&/(&)& $""*&213&+"3(1$)./("*&4"*/#/$"U&'/%X&$1%)-."& (,##"(("(U&-,%&%1&4)="&413"&3)+/*&+31E3"((& '"&4)Y&$""*&%1&-"&(4)3%"3&)-1,%&X1'&'"&,("& )..&%X"&E"$14/#&*)%):
51$0$,"*&1F"3.")2
10'1"#-"19'.).&7:1.;
Advancing Discoveries to Beat Cancer
51$0$,"*
Pd&OWnh!&dh^V *1+%9.'.4#",%?*-9%@@=ABC#"$"'-%=0'1"#%D.4',02.'% @?0#,%E.#%FG1"))"'1"%*'%=0'1"#%C#"$"'2.'%A"("0#19:% A7"%3(%&$*)#0,&,(@2G0$HI,($*#5%0/2'*#,(5*($"#$&%(4%&-&#'*#( %&,&"%$6(0#(/%&",5E($&%-0$".E($*.*%&$5".("#3(4%*,5"5&($"#$&%, WX"&94"3/#)$&9((1#/)01$&213&5)$#"3&!"(")3#X&)$*&%X"&D3"F"$%&5)$#"3&S1,$*)01$& X)(&X1$1,3"*&D312"((13&T)#=&5,o/#=U&5!7862,$*"*&"+/*"4/1.1E/(%&)%&p,""$&`)3Y& 7$/F"3(/%Y&12&a1$*1$U&'/%X&%X"&?@A?&995!6D3"F"$%&5)$#"3&S1,$*)01$&9')3*&213& hG#".."$#"&/$&5)$#"3&D3"F"$01$&!"(")3#X:&WX"&)')3*&/(&E/F"$&)$$,)..Y&213&("4/$).& .)-13)%13YU&%3)$(.)01$).U&#./$/#).U&"+/*"4/1.1E/#).&13&-"X)F/1,3).&(#/"$#"$6 %3/-,01$(&%1&%X"&g".*&12&#)$#"3&+3"F"$01$:&D312&5,o/#=&4)*"&="Y&*/(#1F"3/"(&/$& #X"41+3"F"$01$&12&-3")(%&#)$#"3&,(/$E&%)41G/2"$&)$*U&.)%"3U&)$)(%31o1."U&%X"&3/(=& 12&*"F".1+/$E&-3")(%&#)$#"3U&)$*.13"#%).&)$*&#"3F/#).&#)$#"3&(#3""$/$E:
5!W&7DN9Wh
A look back at 2012 ^"&%)="&)&.11=&-)#=&)%&(14"&12&5!W[(&)#X/"F"4"$%(&*,3/$E&?@A?U&)&Y")3&/$&'X/#X& we celebrated our 10th anniversary. Click on the links below to read in full. A@BK&QQL6QI?:&NOPK&A@:A@MbR dhT`1)AAAL?@M Read in full here Further reading 5:&V')$%1$&>?@A?B:&CP$%3)%,413&X"%"31E"$"6 /%YK&"F1.,01$&%X31,EX&(+)#"&)$*&04":_&Cancer Res.&J?>AIBKHQJM6Q?:&NOPK&A@:AAMQR@@@Q6MHJ?: 59d6A?6??AJ Read in full here
DATES FOR THE DIARY 5!W&3"+3"("$%)0F"(&'/..&-"&)j"$*/$E&%X"("&,+#14/$E&"F"$%( @MJN%OPQR
Bio‐Europe Spring
AACR
S8T%OPQR
S"-&?J&c&`)3#X&? V)$&9$%1$/1U&W"G)(
`)3&AA&c&`)3#X&AL Barcelona
9+3&b&c&9+3/.&A@ ^)(X/$E%1$
9+3&??&c&9+3/.&?M Chicago
10'1"#-"19'.).&7:1.;
